Multi‐Targeting Phytochemicals for Alzheimer's Disease
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1867021995051319296 |
|---|---|
| author | Radha Shree Bhattacharya Raghuraj Singh Archna Panghal Ashima Thakur Lachhman Singh Rahul Kumar Verma Charan Singh Manoj Goyal Jayant Kumar |
| author_facet | Radha Shree Bhattacharya Raghuraj Singh Archna Panghal Ashima Thakur Lachhman Singh Rahul Kumar Verma Charan Singh Manoj Goyal Jayant Kumar Radha Shree Bhattacharya Raghuraj Singh Archna Panghal Ashima Thakur Lachhman Singh Rahul Kumar Verma Charan Singh Manoj Goyal Jayant Kumar |
| collection | Wiley Open Access |
| contents | Multi‐Targeting Phytochemicals for Alzheimer's Disease Radha Shree Bhattacharya Raghuraj Singh Archna Panghal Ashima Thakur Lachhman Singh Rahul Kumar Verma Charan Singh Manoj Goyal Jayant Kumar Phytotherapy Research ABSTRACTAlzheimer's disease (AD) is a type of neurodegenerative illness in which β‐amyloid (Aβ) and tau protein accumulate in neurons in the form of tangles. The pathophysiological pathway of AD consists of Aβ‐amyloid peptides, tau proteins, and oxidative stress in neurons and increased neuro‐inflammatory response. Food and Drug Administration in the United States has authorized various drugs for the effective treatment of AD, which include galantamine, rivastigmine, donepezil, memantine, sodium oligomannate, lecanemab, and aducanumab. The major disadvantage of these drugs is that they only provide “symptomatic” relief. They are most effective in the early stages or for mild to moderate cases of the disease, but are not suitable for long‐term use. Besides conventional therapies, phytochemicals have the potential to stop the progression of AD. According to research, the use of potential phytochemicals against AD has gained attention due to their potent anti‐inflammatory, antioxidant, anti‐hyperphosphorylation of the tau protein, metal chelation, and anti‐amyloid properties. This study seeks to provide an up‐to‐date compilation of the most current and promising breakthroughs in AD therapy using phytochemicals. It could be concluded that phytochemicals light serve as an effective therapy for AD. However, more mechanistic investigations are needed to determine the clinical implications of phytochemicals in AD treatment. 10.1002/ptr.8435 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1002/ptr.8435 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_ptr_8435 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2025 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Multi‐Targeting Phytochemicals for Alzheimer's Disease Radha Shree Bhattacharya Raghuraj Singh Archna Panghal Ashima Thakur Lachhman Singh Rahul Kumar Verma Charan Singh Manoj Goyal Jayant Kumar Phytotherapy Research Multi‐Targeting Phytochemicals for Alzheimer's Disease Radha Shree Bhattacharya Raghuraj Singh Archna Panghal Ashima Thakur Lachhman Singh Rahul Kumar Verma Charan Singh Manoj Goyal Jayant Kumar Phytotherapy Research ABSTRACTAlzheimer's disease (AD) is a type of neurodegenerative illness in which β‐amyloid (Aβ) and tau protein accumulate in neurons in the form of tangles. The pathophysiological pathway of AD consists of Aβ‐amyloid peptides, tau proteins, and oxidative stress in neurons and increased neuro‐inflammatory response. Food and Drug Administration in the United States has authorized various drugs for the effective treatment of AD, which include galantamine, rivastigmine, donepezil, memantine, sodium oligomannate, lecanemab, and aducanumab. The major disadvantage of these drugs is that they only provide “symptomatic” relief. They are most effective in the early stages or for mild to moderate cases of the disease, but are not suitable for long‐term use. Besides conventional therapies, phytochemicals have the potential to stop the progression of AD. According to research, the use of potential phytochemicals against AD has gained attention due to their potent anti‐inflammatory, antioxidant, anti‐hyperphosphorylation of the tau protein, metal chelation, and anti‐amyloid properties. This study seeks to provide an up‐to‐date compilation of the most current and promising breakthroughs in AD therapy using phytochemicals. It could be concluded that phytochemicals light serve as an effective therapy for AD. However, more mechanistic investigations are needed to determine the clinical implications of phytochemicals in AD treatment. 10.1002/ptr.8435 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | Multi‐Targeting Phytochemicals for Alzheimer's Disease |
| topic | Phytotherapy Research |
| url | https://onlinelibrary.wiley.com/doi/10.1002/ptr.8435 |